Consolidated Planning Corp Invests $296,000 in Globe Life Inc. (NYSE:GL)

Consolidated Planning Corp purchased a new stake in shares of Globe Life Inc. (NYSE:GL - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,650 shares of the company's stock, valued at approximately $296,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. State Street Corp increased its position in Globe Life by 3.4% in the third quarter. State Street Corp now owns 3,545,272 shares of the company's stock worth $375,480,000 after buying an additional 115,432 shares during the period. Geode Capital Management LLC increased its position in Globe Life by 3.5% in the third quarter. Geode Capital Management LLC now owns 2,618,764 shares of the company's stock worth $276,994,000 after buying an additional 89,299 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Globe Life by 22.3% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,519,675 shares of the company's stock worth $160,949,000 after buying an additional 277,108 shares during the period. Nuance Investments LLC increased its position in Globe Life by 155.6% in the third quarter. Nuance Investments LLC now owns 1,138,978 shares of the company's stock worth $120,629,000 after buying an additional 693,346 shares during the period. Finally, Pzena Investment Management LLC increased its position in Globe Life by 8.4% in the third quarter. Pzena Investment Management LLC now owns 1,008,732 shares of the company's stock worth $106,835,000 after buying an additional 78,354 shares during the period. 81.61% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Morgan Stanley increased their price target on Globe Life from $123.00 to $125.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 11th. Piper Sandler increased their price target on Globe Life from $118.00 to $130.00 and gave the stock an "overweight" rating in a research note on Friday, October 25th. Keefe, Bruyette & Woods increased their price target on Globe Life from $137.00 to $145.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 12th. Jefferies Financial Group increased their price target on Globe Life from $107.00 to $114.00 and gave the stock a "hold" rating in a research note on Tuesday, December 10th. Finally, BMO Capital Markets assumed coverage on Globe Life in a research note on Thursday, January 23rd. They issued a "market perform" rating and a $114.00 price target for the company. Five equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $133.10.

Globe Life Price Performance

GL stock traded down $1.74 during trading hours on Monday, hitting $121.80. 526,009 shares of the stock traded hands, compared to its average volume of 510,240. The stock has a 50-day simple moving average of $115.01 and a 200 day simple moving average of $108.39. Globe Life Inc. has a one year low of $38.95 and a one year high of $132.00. The company has a market cap of $10.22 billion, a P/E ratio of 10.19 and a beta of 0.81. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50.

Globe Life (NYSE:GL - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, beating analysts' consensus estimates of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. Equities analysts forecast that Globe Life Inc. will post 13.57 earnings per share for the current year.

Insider Activity at Globe Life

In related news, CEO Frank M. Svoboda sold 11,000 shares of the stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $122.31, for a total value of $1,345,410.00. Following the completion of the sale, the chief executive officer now directly owns 18,948 shares of the company's stock, valued at approximately $2,317,529.88. This represents a 36.73 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO James Matthew Darden sold 24,890 shares of the stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $121.52, for a total value of $3,024,632.80. Following the completion of the sale, the chief executive officer now directly owns 38,973 shares of the company's stock, valued at approximately $4,735,998.96. This represents a 38.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 75,678 shares of company stock worth $8,799,822 in the last quarter. 1.51% of the stock is owned by company insiders.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.